U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
--------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Rosenwald, Lindsay A.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
787 Seventh Avenue, 48th Floor
--------------------------------------------------------------------------------
(Street)
New York, NY 10019
--------------------------------------------------------------------------------
(City) (State) (Zip)
10/14,1999
--------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
July 27, 2000
--------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)
--------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Keryx BioPharmaceuticals, Inc. (KERX)
--------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
|X| Director |X| 10% Owner
|_| Officer (give title below) |_| Other (specify below)
________________________________________
--------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
--------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check applicable line)
|X| Form filed by One Reporting Person
|_| Form filed by More than One Reporting Person
================================================================================
--------------------------------------------------------------------------------
Table I -- Non-Derivative Securities Beneficially Owned
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock 5,496,750 D
-----------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
* If the Form is filed by more than one Reporting Person see instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
Page 1 of 2
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------------------------
5. Owner-
3. Title and Amount of Securities ship
Underlying Derivative Security Form of
2. Date Exercisable (Instr. 4) Derivative
and Expiration Date --------------------------------- 4. Conver- Security:
(Month/Day/Year) Amount sion or Direct 6. Nature of
---------------------- or Exercise (D) or Indirect
Date Expira- Number Price of Indirect Beneficial
1. Title of Derivative Exer- tion of Derivative (I) Ownership
Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Series A Convertible
Preferred Stock Immed. Common Stock 70,301 1 for 51.54 D
------------------------------------------------------------------------------------------------------------------------------------
Series A Convertible
Preferred Stock Immed. Common Stock 250,485 1 for 51.54 I (1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock Warrants 12/14/1999 12/14/2009 Common Stock 14,064 $0.0067 D
------------------------------------------------------------------------------------------------------------------------------------
Common Stock Warrants 12/14/1999 12/14/2009 Common Stock 50,110 $0.0067 I (1)
------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) These shares are owned by Paramount Capital Investments, LLC, an
affiliate of Paramount Capital Inc., of which Dr. Rosenwald is Chairman and
which he may therefore be deemed to beneficially own. Dr. Rosenwald disclaims
beneficial ownership of these shares to the extent of his pecuniary interest
therein.
/s/ Lindsay A. Rosenwald, M.D. July 27, 2000
--------------------------------------------- -----------------------
** Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
Page 2 of 2
